Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Idealab is a pioneering technology incubator and venture studio founded by Bill Gross in 1996. Based in Pasadena, California, the company focuses on identifying disruptive ideas and providing the necessary resources, capital, and operational expertise to spin them off into independent, market-leading companies. While its portfolio spans a wide range of sectors including energy and robotics, Idealab has a significant history in the life sciences and healthcare, notably co-founding Synthetic Genomics (now Viridos) and incubating various health-tech startups. The company operates as a centralized platform for innovation, leveraging decades of experience to support its diverse array of portfolio companies from initial concept through to commercialization and exit.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Idealab.